Zobrazeno 1 - 10
of 130
pro vyhledávání: ''
Autor:
Marko Kadija, Emilija Dubljanin Raspopović, Winfried Meissner, Goran Tulic, Sanja Tomanović Vujadinović, Ruth Zaslansky
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 7, p e0253147 (2021)
PLoS ONE, Vol 16, Iss 7, p e0253147 (2021)
Introduction/Aim Early rehabilitation, return to daily life activities and function are the ultimate goals of perioperative care. It is unclear which pain-related patient-reported outcome measures (PROM) mirror treatment effects or are related with e
Autor:
Stephan Ehlers, Mats Johnson, Susanna M. Wallerstedt, Parisa Hajjari, Elisabeth Fernell, Constanze Wartenberg
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 7, p e0253844 (2021)
PLoS ONE, Vol 16, Iss 7, p e0253844 (2021)
ObjectiveTo assess effects of treatment against a hypothesized neuroinflammation in children with symptoms corresponding to the research condition Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) which is not included in current diagnostic syst
Autor:
Jaime Altcheh, Luis Castro, Juan C Dib, Ulrike Grossmann, Erya Huang, Guillermo Moscatelli, Jimy José Pinto Rocha, Teresa Estela Ramírez, CHICO Study Group
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS Neglected Tropical Diseases, Vol 15, Iss 1, p e0008912 (2021)
PLoS Neglected Tropical Diseases
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS Neglected Tropical Diseases, Vol 15, Iss 1, p e0008912 (2021)
PLoS Neglected Tropical Diseases
Nifurtimox is a recommended treatment for Chagas disease, but data from treated children are limited. We investigated the efficacy, safety and tolerability of nifurtimox administered as divisible, dispersible 30 mg and 120 mg tablets in children with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21712d252180e11362346c2556b2f933
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008912
https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008912
Autor:
Marie Gerardin, Morgane Rousselet, Marie-Laure Couec, Agathe Masseau, Marylène Guerlais, Nicolas Authier, Sylvie Deheul, Anne Roussin, Joelle Micallef, Samira Djezzar, French Addictovigilance Network (FAN), Fanny Feuillet, Pascale Jolliet, Caroline Victorri-Vigneau
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 3, p e0248649 (2021)
PLoS ONE, Vol 16, Iss 3, p e0248649 (2021)
Background Sickle cell disease (SCD) induces chronic haemolytic anaemia and intermittent vaso-occlusion that results in tissue ischaemia causing acute, severe pain episodes that can lead to frequent hospitalizations. These consequences can have reper
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 2, p e0246463 (2021)
PLoS ONE, Vol 16, Iss 2, p e0246463 (2021)
Diazoxide is the first-line drug for treating hyperinsulinism and the only pharmacological agent approved for hyperinsulinism by the Federal Drug Administration. This systemic review and meta-analysis aimed to investigate the efficacy and safety of d
Autor:
Marianne Haedener, Michael Liebrenz, Dominique Eich, Anna Buadze, Wolfgang Weinmann, Thomas Wuethrich
Publikováno v:
Haedener, Marianne; Weinmann, Wolfgang; Eich, Dominique; Liebrenz, Michael; Wüthrich, Thomas; Buadze, Anna (2021). Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine. PLoS ONE, 16(3), e0248747. Public Library of Science 10.1371/journal.pone.0248747
PLoS ONE
PLoS ONE, Vol 16, Iss 3, p e0248747 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 3, p e0248747 (2021)
Considering the high clinical and forensic relevance of pharmaco-adherence during lisdexamphetamine (LDX) treatment for attention-deficit/hyperactivity disorder (ADHD), the aim here was to evaluate hair analysis as a tool for monitoring compliance in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4f3b73d405b6e0a792f5ddff4613d81
https://boris.unibe.ch/155738/1/journal.pone.0248747.pdf
https://boris.unibe.ch/155738/1/journal.pone.0248747.pdf
Autor:
A. Abakar Mahamat, N. Mathé, Roger Faroux, R. Boustany, P. Soulié, L. Moreau, Isabelle Baumgaertner, R. Hervé, J. M. Phelip, D. Smith, J. M. Bons, L. Vazquez, Laurent Miglianico, Eric Francois, Rosine Guimbaud, Laurent Mineur, Louis-Marie Dourthe, A. L. Villing, S. Remy, E. Achille, N. Bonichon, Carine Plassot, I. Rabbia
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 12, p e0243997 (2020)
PLoS ONE, Vol 15, Iss 12, p e0243997 (2020)
Background Cetuximab improves progression-free survival (PFS) and overall survival (OS) in patients with KRAS wild type (wt) metastatic colorectal cancer (mCRC). Few data are available on factors impacting both efficacy and compliance to cetuximab tr
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 10, p e0241230 (2020)
PLoS ONE, Vol 15, Iss 10, p e0241230 (2020)
Optical coherence tomography angiography (OCTA) is a novel, non-invasive imaging tool used to detect vascular flow. The absence of a flow signal in OCTA in polyps revealed by indocyanine green angiography (ICGA) in patients with polypoidal choroidal
Autor:
K.-S. Park, Young-Woo Jeon, Joo-Hyun O, Byung-Ock Choi, Seung-Eun Jung, Han Hee Lee, Hye Jin Kang, Seok-Goo Cho
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 9, p e0238807 (2020)
PLoS ONE, Vol 15, Iss 9, p e0238807 (2020)
PurposeThe optimal treatment for primary gastric diffuse large B-cell lymphoma (PG-DLBCL) is still unknown. We evaluated unfavorable prognostic factors and pattern of failure in PG-DLBCL to determine the optimal treatment strategy.MethodsBetween Apri
Autor:
Ciapponi, Agustín, Barreira, Fabiana, Perelli, Lucas, Bardach, Ariel, Gascon, Joaquim, Molina Romero, Israel, Morillo, Carlos, Prado, Nilda, Riarte, Adelina, Torrico, Faustino, Ribeiro, Isabela, Villar, Juan Carlos, Sosa-Estani, Sergio, Universitat Autònoma de Barcelona
Publikováno v:
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS Neglected Tropical Diseases, Vol 14, Iss 8, p e0008529 (2020)
PLoS Neglected Tropical Diseases
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
PLoS Neglected Tropical Diseases, Vol 14, Iss 8, p e0008529 (2020)
PLoS Neglected Tropical Diseases
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Chagas disease is a neglected disease that remains a public health threat, particularly in Latin America. The most important treatment options are nitroimidazole derivatives, such as nifurtimox and benznidazole (BZN). Some studies suggest that for ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0d92cc1bd5a5c8440c57d9544b7a239